Agilent Technologies Inc. Expands Life Science Disease Research Portfolio with Eurofins MWG Operon Asset Purchase

Published: Nov 16, 2009

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE:A) today announced it has purchased the MassCode Tag technology from Eurofins MWG Operon, a division of Eurofins. The purchase includes the MassCode trademarks and intellectual property, including four families of patents. Agilent will use MassCode Tag technology to develop new research products for pathogen identification, leveraging its strength in polymerase chain reaction (PCR) and mass spectroscopy. Under the agreement, Eurofins MWG Operon will continue as a supplier of the core component for the new products.

Back to news